Top 10 Logistics Companies To Buy Right Now

When it comes to the highly charged biodiesel industry, one company stands above the rest. Way above. Renewable Energy Group (NASDAQ: REGI  ) is not only the leader in terms of pure production capacity, but it also displays plenty of desirables that should be on every investor's radar. What makes the company so great? It is no secret. In particular, REG has focused on three areas to become the top biodiesel stock.

1. Focus on infrastructure
A lot of investors get giddy with excitement when talking about the distribution and logistics network of Clean Energy Fuels (NASDAQ: CLNE  ) . It may produce compressed natural gas for commercial truck fleets, but it has a lot in common with REG. Don't believe me? Take a look at Clean Energy Fuel's distribution network:

Source: Clean Energy Fuels. �

And see how it compares with that of REG:

Source: Renewable Energy Group.

10 Best Railroad Stocks To Own Right Now: Fortescue Metals Group Ltd (FSUMF)

Fortescue Metals Group Limited (Fortescue) is an iron ore producer and explorer operating in the Pilbara region of Western Australia. Fortescue is engaged in mining of iron ore from its Cloudbreak and Christmas Creek mine sites, the operation of an integrated mine, rail and port supply chain and the expansion of iron ore operations. Its Cloudbreak mine site is located in the Chichester Ranges in the Pilbara region of Western Australia, 263 kilometers (km) south of Port Hedland and 150km north of Newman. Its Christmas Creek is second mining operation, 50 km to the east of Cloudbreak. The Company has also designed and constructed rail and port facilities to support the development and sale of the Pilbara's stranded iron ore bodies. Its subsidiaries include The Pilbara Infrastructure Pty Limited, FMG Pilbara Pty Limited, Chichester Metals Pty Limited, Pilbara Mining Alliance Pty Limited, and Karribi Developments Pty Limited. Advisors' Opinion:

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- Australian stocks rose in early Monday trading, helped by Wall Street's gains Friday, with the S&P/ASX 200 (AU:XJO) climbing 0.8% to 5,362.40 after closing the previous session at its highest level since before the start of the 2008 financial crisis. Miners were broadly improving, as Fortescue Metals Group Ltd. (AU:FMG) (FSUMF) rose 1.3%, BHP Billiton Ltd. (AU:BHP) (BHP) added 0.9% ahead of its quarterly production report Tuesday, and Newcrest Mining Ltd. (AU:NCM) (NCMGF) also climbed 0.9% despite a loss for gold at the end of last week. Financials saw gains as well, with many analysts now tipping the U.S. Federal Reserve to maintain its current level of easing through the end of the year. Australia & New Zealand Banking Group (AU:ANZ) (ANEWF) advanced 1.1%, while Westpac Banking Corp. (AU:WBC) (WEBNF) and Macquarie Group Ltd. (AU:MQG) (MCQEF) rose 1.2% each. On the downside, shares of Qantas Airways Ltd. (AU:QAN) (QUBSF) fell 4.2% after the company warned of rough business conditions on Friday.

• [By MARKETWATCH]

  LOS ANGELES (MarketWatch) -- Australian stocks nudged modestly higher early Thursday, with a rebound for financials offsetting weakness in the resource space. The S&P/ASX 200 (AU:XJO) advanced 0.1% to 5,361.80, as banks and brokers gained after losing ground late in the previous session on concerns about the health of major Chinese banks. Commonwealth Bank of Australia (AU:CBA) (CBAUF) and Macquarie Group Ltd. (AU:MQG) (MCQEF) rose 0.7% apiece, Australia & New Zealand Banking Group (AU:ANZ) (ANEWF) added 0.5%, and Westpac Banking Corp. (AU:WBC) (WEBNF) improved by 0.5%. On the downside, losses for gold futures overnight sent Newcrest Mining Ltd. (AU:NCM) (NCMGF) down 1.3% and Evolution Mining Ltd. (AU:EVN) (CAHPF) 2.3% lower. The broader mining sector was also lower, with Alumina Ltd. (AU:AWC) (AWCMF) off 2.8%, BHP Billiton Ltd. (AU:BHP) (BHP) down 0.5%, and Fortescue Metals Group Ltd. (AU:FMG) (FSUMF)

• [By WWW.MARKETWATCH.COM]

  LOS ANGELES (MarketWatch) -- A soft lead from Wall Street and uncertainty ahead of Australian retail sales data (and U.S. jobs data) aren't slowing the Sydney market, where the S&P/ASX 200 stock benchmark is up 0.5% early Thursday, mainly on a gains for commodities. With copper at a fourth-month high and Chinese spot iron-ore prices moving further off their recent lows, Australia's heavily weighted mining stocks are trading broadly higher: BHP Billiton Ltd. (AU:BHP) (BHP) is up 0.7%, Rio Tinto Ltd. (AU:RIO) (RIO) is up 0.5%, Fortescue Metals Group Ltd. (AU:FMG) (FSUMF) is up 2.5%, Mount Gibson Iron Ltd. (AU:MGX) is up 3.7%, Oz Minerals Ltd. (AU:OZL) (OZMLF) is up 1.7%, and Newcrest Mining Ltd. (AU:NCM) (NCMGF) is up 1.8%. Casino operator Crown Resorts Ltd. (CWLDF) is up 1.2% as Bell Potter reiterates its buy call on the shares, even as it cuts its target price, according to Dow Jones Newswires. On the downside, David Jones Ltd. (AU:DJS) (DVDJF) is down 0.5% as Australian media reports say the nation's regulators failed to get permission to open an investigation into the retailer's proposed takeover by Woolworths of South Africa.

• [By WWW.MARKETWATCH.COM]

  LOS ANGELES (MarketWatch) -- Australia shares nudged lower early Friday, with the S&P/ASX 200 (AU:XJO) down 0.2% to erase the previous session's 0.2% gain, dragged by losses for European and U.S. equities on the back of a Portuguese financial crisis. Financials fell (Australia & New Zealand Banking Group (AU:ANZ) (ANEWF) and National Australia Bank Ltd. (AU:NAB) (NAUBF) each down 0.3%, Commonwealth Bank of Australia (AU:CBA) (CBAUF) down 0.4%, and Macquarie Group Ltd. (AU:MQG) (MCQEF) down 0.7%), and the top miners fared especially poorly (Rio Tinto Ltd. (AU:RIO) (RIO) down 1.2%, Oz Minerals Ltd. (AU:OZL) (OZMLF) down 1.1%, though BHP Billiton Ltd. (AU:BHP) (BHP) off just 0.1%). And while Atlas Iron Ltd. (AU:AGO) beat its production guidance, and Fortescue Metals Group Ltd. (AU:FMG) (FSUMF) missed its production guidance, both saw losses, with Atlas stock off 2.9% and Fortescue trading 1.6% lower. Among the gainers, Scentre Group

Top 10 Logistics Companies To Buy Right Now: Aqua America Inc.(WTR)

Aqua America, Inc., through its subsidiaries, operates regulated utilities that provide water or wastewater services in the United States. The company serves residential, commercial, fire protection, industrial, and other water and wastewater customers in Pennsylvania, Texas, North Carolina, Ohio, Illinois, New Jersey, New York, Florida, Indiana, Virginia, Maine, Missouri, and Georgia. It also provides water and wastewater services through operating and maintenance contracts with municipal authorities and other parties, as well as sludge hauling, septage and grease services, and backflow prevention services. The company was formerly known as Philadelphia Suburban Corporation and changed its name to Aqua America, Inc. in 2004. Aqua America, Inc. was founded in 1968 and is based in Bryn Mawr, Pennsylvania.

Advisors' Opinion:

• [By Justin Loiseau]

  Is Aqua dried up?
  Aqua America (NYSE: WTR  ) announced this week that Chairman, President, and CEO Nicholas DeBenedictis recently sold around $3 million worth of shares. Management stock sales usually make Wall Street worry that the top dogs know something Mr. Market doesn't. If corporate executives sell stock, they may believe their company is overvalued -- or they may know there's trouble ahead.

• [By Vita Nelson]

  Our latest featured dividend reinvestment idea is Aqua America (WTR). Founded in 1968, and headquartered in Bryn Mawr, Pennsylvania, Aqua America operates regulated utilities that provide water or wastewater services in the United States.

Top 10 Logistics Companies To Buy Right Now: Luminex Corporation(LMNX)

Luminex Corporation engages in the development, manufacture, and sale of proprietary biological testing technologies and products for the life sciences and diagnostic industries. It offers xMAP technology, an open architecture and multiplexing technology that allows simultaneous analysis of approximately 500 bioassays from a drop of fluid by reading biological tests on the surface of microscopic polystyrene beads called microspheres. The company?s xMAP technology is used in various segments of the life sciences industry, such as the fields of drug discovery and development, clinical diagnostics, genetic analysis, bio-defense, food safety, and biomedical research. It operates in two segments, Technology and Strategic Partnerships; and Assays and Related Products. The Technology and Strategic Partnerships segment provides Luminex LX 100/200 that integrates fluidics, optics, and digital signal processing; FLEXMAP 3D system for use as a general laboratory instrument; and MAGP IX system, a multiplexing analyzer for qualitative and quantitative analysis of proteins and nucleic acids. This segment also offers consumables comprising dyed polystyrene microspheres and sheath fluids. The Assays and Related Products segment develops and sells assays on xMAP technology for use on its installed base of systems. This segment?s products are focused on the human genetics, personalized medicine, and infectious disease segments of the genetic testing market. This segment provides various assay products, which consist of a combination of chemical and biological reagents, and company?s proprietary bead technology used to perform diagnostic and research assays on samples. It serves pharmaceutical companies, clinical laboratories, research institutions, and medical institutions in the United States, Europe, Asia, Canada, and Australia. The company was founded in 1995 and is headquartered in Austin, Texas.

Advisors' Opinion:

• [By Markus Aarnio]

  Illumina's competitors include Affymetrix (AFFX), Life Technologies Corporation (LIFE) and Luminex Corporation (LMNX). Here is a table comparing these companies.

• [By Roberto Pedone]

  A health care stock that insiders are jumping into here is Luminex (LMNX), which develops, manufactures and sells proprietary biological testing technologies and products with applications throughout the life sciences and diagnostics industries. Insiders are buying this stock into notable strength, since shares are up 23.2% so far in 2013.

  Luminex has a market cap of $859 million and an enterprise value of $784 million. This stock trades at a premium valuation, with a price-to-sales of 119.83 and a price-to-book of 33.63. Its estimated growth rate for this year is 36.7%, and for next year it's pegged at 51.2%. This is a cash-rich company, since the total cash position on its balance sheet is $42.97 million and its total debt is just $1.67 million.

  A director just bought 27,000 shares, or about $540,000 worth of stock, at $20.01 per share.

  From a technical perspective, LMNX is currently trending above its 200-day and just below is 50-day moving average, which is neutral trendwise. This stock recently gapped down sharply from $23.50 to $19.75 a share with heavy downside volume flows. Following that move, shares of LMNX have started to rebound off $19.75 and the stock is starting to push within range of triggering a near-term breakout trade.

  If you're bullish on LMNX, then look for long-biased trades as long as this stock is trending some key near-term support at $19.75, and then once it breaks out above its 50-day at $21.14 a share and above its gap down day high of $21.83 a share with high volume. Look for a sustained move or close above those levels with volume that hits near or above its three-month average volume of 206,755 shares. If that breakout hits soon, then LMNX will set up to re-test or possibly take out its 52-week high at $24.10. Any high-volume move above that level will then give LMNX a chance to tag $25 to $26.

• [By Garrett Cook]

  In trading on Tuesday, healthcare shares were relative laggards, down on the day by about 0.27 percent. Top losers in the sector includedLuminex (NASDAQ: LMNX), down 11.4 percent, and Sanofi (NYSE: SNY), off 10 percent.

• [By Sean Williams]

  Now what: Normally, a $5 million haircut isn't a big deal. However, if a company is losing money and that $5 million is a clean 14% below its original forecasts, then it's certainly going to garner a negative reaction. It also doesn't help that Natural Molecular Testing Corporation -- that aforementioned "large customer" -- recently entered in a multi-year collaboration with Luminex (NASDAQ: LMNX  ) earlier this month, casting a gray cloud over GenMark's future revenue stream with NMTC. Until we get better visibility from GenMark's management team and see the company moving toward profitability, this is a name I'd suggest keeping your distance from.

Top 10 Logistics Companies To Buy Right Now: St. Jude Medical Inc.(STJ)

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantable cardioverter defibrillator systems to provide therapy to patients suffering from lethal heart conditions, such as sudden cardiac arrest; cardiac resynchronization therapy devices to treat heart failure patients; pacemakers to help people whose hearts beat too slowly or who suffer from other cardiac arrhythmias; and leads, which connect devices to the heart and carry the electrical impulses to the heart and information from the heart to the device. The Cardiovascular segment offers mechanical and tissue replacement heart valves, as well as heart valve repair products. It also pr ovides disposable interventional devices, including vascular closure devices, compression assist devices, percutaneous catheter introducers, diagnostic guidewires, and temporary bipolar pacing catheters, as well as diagnostic coronary imaging technology. The Atrial Fibrillation segment offers a system of products for access, diagnosis, visualization, and ablation that assist physicians in diagnosing and treating various irregular heart rhythms used in the electrophysiology lab and cardiac surgery. It provides electrophysiology introducers and catheters, cardiac mapping, navigation and recording systems, and ablation systems. The Neuromodulation segment offers a range of neurostimulation systems, such as rechargeable implantable pulse generators, primary cell implantable pulse generators, and radio frequency powered systems. St. Jude Medical markets its products through a direct sales force and independent distributors. The company was founded in 1976 and is headquartered in St. Paul, Minnesota.

Advisors' Opinion:

• [By Dan Carroll]

  The Food and Drug Administration has approved�St. Jude Medical's (NYSE: STJ  ) new Ellipse implantable cardioverter defibrillator (ICD) and its Assura cardiac resynchronization therapy defibrillator (CRT-D), high-voltage devices with new safety features.

Top 10 Logistics Companies To Buy Right Now: Activision Blizzard Inc(ATVI)

Activision Blizzard, Inc., through its subsidiaries, publishes online, personal computer (PC), console, and handheld games worldwide. The company develops and publishes PC-based computer games and maintains its proprietary online-game related service, Battle.net. It publishes interactive software products and peripherals. Its products cover various game categories, such as action/adventure, action sports, racing, role-playing, simulation, first-person action, music, and strategy. Activision?s products comprise Monsters vs. Aliens, Guitar Hero, X-Men Origins, PROTOTYPE, Transformers, Ice Age, Wolfenstein, Marvel Ultimate Alliance, Bakugan Battle Brawlers, DJ Hero, Band Hero, Call of Duty, Tony Hawk, Guitar Hero, Three map packs for Call of Duty, True Crime, Spider-Man, Bakugan, Blur, and Singularity. Its customers include retail outlets and distributors, including mass-market retailers, consumer electronics stores, discount warehouses, and game specialty stores. Activision Blizzard, Inc. is based in Santa Monica, California. Activision Blizzard, Inc. operates as a subsidiary of Vivendi.

Advisors' Opinion:

• [By Philip Saglimbeni]

  The system unveil on May 21 lasted about an hour and revealed several interesting facts about the launch version of Microsoft's next console. Here are the highlights:

  System will release 'later this year' at an yet undisclosed price.System includes/will ship with 8GB of RAM, 8-Core CPU, 500 GB hard drive, Blu-ray drive, HDMI in and out ports, USB 3.0, next generation Kinect device.Console referred to as 'all-in-one system' for video games, music, television and movies.System does not require always-online connection to play games.8 games have been confirmed, including major releases from Electronic Arts Inc. (EA) and Activision Blizzard, Inc. (ATVI).Microsoft confirms 15 exclusive Xbox One games in the system's first year.Live-action Halo television series announced, executive produced by Steven Spielberg.Call of Duty: Ghosts DLC will launch first on Xbox One.Partnership with NFL will allow fans to interact with stats/fantasy football features while watching live games.

  Microsoft's live event successfully shed light on many of the next generation Xbox's features that gamers were curious about. Perhaps most importantly, management finally ended the rumor of the always-online connection, which had many potential consumers worrying about their ability to play video games without an Internet connection. It was a smart decision on Microsoft's part to not include this aspect in the Xbox One as it has been attempted before and met with great disappointment. Electronic Arts' recent release of Sim City 5 was a public relations disaster as a majority of gamers were unable to log-in to their accounts and access the actual game, due to the company's insistence on forcing consumers to be constantly connected to the Internet in order to play. More recently, Microsoft faced increased scrutiny over the always-online rumor when Xbox game developer Adam Orth went on a Twitter tirade claiming the benefits of the unpopular idea and had to be fired soon after. Wisely, whether it

• [By Blake Bos]

  Pre-orders for both the Playstation 4 and the Xbox One are sold out on Gamestop, and in this video, Motley Fool consumer goods analyst Blake Bos asks the question, "Does that mean it's time for investors to take a look at game developer stocks?" He compares the three big game developers listed on the U.S. exchanges --�Take-Two Interactive (NASDAQ: TTWO  ) , Electronic Arts (NASDAQ: EA  ) , and Activision Blizzard (NASDAQ: ATVI  ) �-- and gives investors his favorite pick of the bunch.

• [By Kevin Chen]

  In the video below, Fool contributor Kevin Chen outlines how you should think about China's gaming market. Through learning about these companies' successes and failures, you'll get a better understanding for why licensing agreements won't work -- even if it is with Activision Blizzard (NASDAQ: ATVI  ) �-- and how you can profit from the Chinese government's policies. To learn more, watch the video below.

• [By Jason Hall]

  Activision Blizzard� (NASDAQ: ATVI  ) just turned in a smash hit of a third quarter.�

  Revenue came in well above the company's -- and Wall Street analysts' -- projections. Earnings on both a GAAP and non-GAAP basis more than doubled expectations:

Top 10 Logistics Companies To Buy Right Now: American Railcar Industries Inc.(ARII)

American Railcar Industries, Inc. designs, manufactures, and sells hopper and tank railcars in North America. Its Manufacturing Operations segment manufactures general service and specialty hopper railcars that are used to transport, load, and unload grains, cement, plastic pallets, and bulk products, as well as to transport heavy ore mineral loads; and non-pressure and high pressure tank railcars used to handle various commodities, including petroleum products, ethanol, asphalt, vegetable oil, corn syrup, other food products, chlorine, anhydrous ammonia, liquid propane, and butane. This segment also manufactures custom and standard railcar components that comprise tank railcar components and valves, tank heads, discharge outlets for hopper railcars, manway covers and valve body castings, outlet components and running boards for industrial and railroad customers, and hitches for the intermodal market; and aluminum and special alloy steel castings for the trucking, construc tion, mining, and oil and gas exploration markets, as well as finished machined aluminum castings and other custom machined products. The company?s Railcar Services segment provides repair and refurbishment services that include full cleaning, interior and exterior coating, heavy repair/rebuilding, and non-destructive testing; engineering services, such as failure analysis, retrofit drawings, procedure preparation, regulatory compliance assistance, trouble shooting, and railcar inspections; and fleet management services comprising maintenance planning, project management, tracking and tracing, regulatory compliance, mileage audit, rolling stock taxes, and online service access. It sells its products through catalogs and sales force to leasing, industrial, and other non-rail companies, as well as to railroads. The company was founded in 1988 and is headquartered in St. Charles, Missouri. As of January 15, 2010, American Railcar Industries, Inc. operates as subsidiary of Icah n Enterprises L.P.

Advisors' Opinion:

• [By Dan Caplinger]

  Bullish economic news helped the Dow finally hold onto the 16,000 level at the end of the day, even after three previous forays had failed to result in a close above that figure. Even amid the general enthusiasm over stocks as the year draws to a close, GameStop (NYSE: GME  ) , American Railcar Industries (NASDAQ: ARII  ) , and Tower Group International (NASDAQ: TWGP  ) all fell sharply. Let's figure out why these stocks dropped so badly and what their moves could mean for the broader market.

Top 10 Logistics Companies To Buy Right Now: CollabRx Inc (CLRX)

CollabRx, Inc., incorporated on September 20, 1995, is focused on developing and delivering content knowledge-based products and services that inform healthcare decision-making, with an emphasis on genomics-based precision medicine and big data analytics. The Company delivers content to users through Web-based applications and services in the cloud serving physicians and their patients in two settings: at the point-of-care in the clinic and indirectly, as a part of a genetic test report provided to an ordering physician by a diagnostic testing laboratory, (lab). The Company�� Therapy Finder Web-based application serves as an initial user-interface to the underlying knowledge base. It is available free of charge on its Website. In addition, a professional version is offered to registered physicians through MedPage Today, an offering of Everyday Health, Inc.

The Company�� offering provides the clinical interpretation of genetic variants present in human tumor biopsies, and is sold directly to diagnostic labs that perform molecular testing on patients. Its Genetic Variant Application (GVA) is compiled by its software platform to provide specific insights to a patient�� diagnostic test results on a test-by-test basis. The GVA results are provided to laboratories in a variety of forms, including with a front-end user Interface (UI) or directly integrated into a customer�� laboratory information management system (LIMS). The Company�� content is identified as Powered by CollabRx within the test report. Portions of its Web-based applications are available free to physicians and patients through commercial on-line media partners under a license and advertising or sponsorship revenue sharing arrangement. The content that, the Company offers to laboratories is sold based on a variation of Software as a service (SaaS) business model, in which its content is provided on a one-time, subscription or per test basis. It also receives fee-for-service payments in connection with customized user ! interfaces to its database.

Advisors' Opinion:

• [By James E. Brumley]

  On the surface it's the kind of thing the market doesn't want to see. In reality though, CollabRx Inc. (NASDAQ:CLRX) will be far better off - and far batter positioned to reward shareholders - by doing what needs to be done in order to continue capitalizing on the opportunity it has in front of it. And what exactly did CLRX do? It raised some money by shares it had sitting on the shelf.

• [By John Udovich]

  One way or the other, Merrimack Pharmaceuticals Inc (NASDAQ: MACK), Covidien plc (NYSE: COV), NeoGenomics, Inc (NASDAQ: NEO) and�CollabRx Inc (NASDAQ: CLRX) are targeting Barrett's Esophagus�or�esophageal cancer�(the former often leads to the latter) ��a form of cancer that may not be on the top of your list of cancers but is nevertheless on the rise. Approximately 3 million Americans suffer from Barrett's Esophagus, �a condition that�develops as a result of chronic injury from gastroesophageal reflux disease (GERD) where the�normal esophageal lining is replaced with abnormal cells (known as Barrett�� tissue), putting patients at greater risk of developing cancer of the esophagus. And although less than 1% of these patients develop cancer each year, esophageal carcinoma is frequently not detected until later stages, at which point therapy options are limited, extremely invasive, and often ineffective.�This means that�early detection is important�along with�regular surveillance is recommended.�

• [By James E. Brumley]

  If you were lucky enough to own WebMD Health Corp. (NASDAQ:WBMD) before the end of last week, then congratulations - you're up 20% today. And if you didn't get into WBMD before the close of business on Friday, well, it may be too late to step into it now (unless you like buying overextended stocks), but if you believe in the ongoing convergence of healthcare and digital information though - which is what put WebMD on the map - then you may want to take a closer look at CollabRx Inc. (NASDAQ:CLRX).